These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33728965)
1. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease. Nicolas J; Razuk V; Giustino G; Mehran R Future Cardiol; 2021 May; 17(3):521-534. PubMed ID: 33728965 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus. Capodanno D; Angiolillo DJ Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005 [TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease. Ferreiro JL; Cequier ÁR; Angiolillo DJ Diab Vasc Dis Res; 2010 Oct; 7(4):274-88. PubMed ID: 20921091 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention. Siasos G; Skotsimara G; Oikonomou E; Sagris M; Vasiliki-Chara M; Bletsa E; Stampouloglou P; Theofilis P; Charalampous G; Tousoulis D Curr Pharm Des; 2020; 26(23):2780-2788. PubMed ID: 32303164 [TBL] [Abstract][Full Text] [Related]
5. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen. Kawakami S; Yasuda S; Ogawa H J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534 [TBL] [Abstract][Full Text] [Related]
7. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
16. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies. Barbieri L; Verdoia M; Schaffer A; Suryapranata H; De Luca G Cardiovasc Drugs Ther; 2016 Dec; 30(6):611-622. PubMed ID: 27757726 [TBL] [Abstract][Full Text] [Related]
17. Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Camaj A; Miller MS; Halperin JL; Giustino G Cardiol Clin; 2020 Nov; 38(4):551-561. PubMed ID: 33036717 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry. Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277 [TBL] [Abstract][Full Text] [Related]
19. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]